These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38267906)
1. TIM-3/Galectin-9 interaction and glutamine metabolism in AML cell lines, HL-60 and THP-1. Shapourian H; Ghanadian M; Eskandari N; Shokouhi A; Demirel GY; Bazhin AV; Ganjalikhani-Hakemi M BMC Cancer; 2024 Jan; 24(1):125. PubMed ID: 38267906 [TBL] [Abstract][Full Text] [Related]
2. TIM-3/Gal-9 interaction affects glucose and lipid metabolism in acute myeloid leukemia cell lines. Rezaei M; Ghanadian M; Ghezelbash B; Shokouhi A; Bazhin AV; Zamyatnin AA; Ganjalikhani-Hakemi M Front Immunol; 2023; 14():1267578. PubMed ID: 38022614 [TBL] [Abstract][Full Text] [Related]
3. Oridonin Could Inhibit Inflammation and T-cell Immunoglobulin and Mucin-3/Galectin-9 (TIM-3/Gal-9) Autocrine Loop in the Acute Myeloid Leukemia Cell Line (U937) as Compared to Doxorubicin. Nasri F; Sadeghi F; Behranvand N; Samei A; Bolouri MR; Azari T; Abdollahi E; Ghazizadeh F; Motevalian M; Hassan ZM; Falak R Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):602-611. PubMed ID: 33463129 [TBL] [Abstract][Full Text] [Related]
4. Negative regulation of TIM-3 expression in AML cell line (HL-60) using miR-330-5p. Fooladinezhad H; Khanahmad H; Ganjalikhani-Hakemi M; Doosti A Br J Biomed Sci; 2016 Jul; 73(3):129-133. PubMed ID: 27341144 [TBL] [Abstract][Full Text] [Related]
5. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression]. Kikushige Y Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443 [TBL] [Abstract][Full Text] [Related]
6. Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes. Matre P; Velez J; Jacamo R; Qi Y; Su X; Cai T; Chan SM; Lodi A; Sweeney SR; Ma H; Davis RE; Baran N; Haferlach T; Su X; Flores ER; Gonzalez D; Konoplev S; Samudio I; DiNardo C; Majeti R; Schimmer AD; Li W; Wang T; Tiziani S; Konopleva M Oncotarget; 2016 Nov; 7(48):79722-79735. PubMed ID: 27806325 [TBL] [Abstract][Full Text] [Related]
7. [Effects of Li Y; Shi LH; Xie X; Fan PK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1599-1607. PubMed ID: 38071034 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the effect of TIM-3 suppression by miR-498 and its effect on apoptosis and proliferation rate of HL-60 cell line. Moghaddam Y; Andalib A; Mohammad-Ganji M; Homayouni V; Sharifi M; Ganjalikhani-Hakemi M Pathol Res Pract; 2018 Sep; 214(9):1482-1488. PubMed ID: 30107988 [TBL] [Abstract][Full Text] [Related]
10. Differential expression and biochemical activity of the immune receptor Tim-3 in healthy and malignant human myeloid cells. Gonçalves Silva I; Gibbs BF; Bardelli M; Varani L; Sumbayev VV Oncotarget; 2015 Oct; 6(32):33823-33. PubMed ID: 26413815 [TBL] [Abstract][Full Text] [Related]
11. C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation. Al Shahrani M; Gahtani RM; Makkawi M Med Oncol; 2024 Jan; 41(3):63. PubMed ID: 38265498 [TBL] [Abstract][Full Text] [Related]
12. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414 [TBL] [Abstract][Full Text] [Related]
13. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia]. Sakoda T; Kikushige Y Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480 [TBL] [Abstract][Full Text] [Related]
14. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4 Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217 [TBL] [Abstract][Full Text] [Related]
15. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus. Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439 [TBL] [Abstract][Full Text] [Related]
16. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells. Gonçalves Silva I; Yasinska IM; Sakhnevych SS; Fiedler W; Wellbrock J; Bardelli M; Varani L; Hussain R; Siligardi G; Ceccone G; Berger SM; Ushkaryov YA; Gibbs BF; Fasler-Kan E; Sumbayev VV EBioMedicine; 2017 Aug; 22():44-57. PubMed ID: 28750861 [TBL] [Abstract][Full Text] [Related]
17. Glutaminase 1 plays critical roles in myelodysplastic syndrome and acute myeloid leukemia cells. Okabe S; Moriyama M; Arai Y; Gotoh A Cancer Biomark; 2024; 41(1):55-68. PubMed ID: 39213050 [TBL] [Abstract][Full Text] [Related]
18. [Effect of Competitive Antagonist of Transmembrane Glutamine Flux V-9302 on Apoptosis of Acute Myeloid Leukemia Cell Lines HL-60 and KG-1]. Li QQ; Pan SY; Chen QY; Zhou W; Wang SQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):685-689. PubMed ID: 34105457 [TBL] [Abstract][Full Text] [Related]
19. [Effect of rhTPO to the Proliferation and Apoptosis of Acute Myeloid Leukemia Cell Lines]. Wang N; Lyu N; Min X; Wang LL; Zhu HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):389-394. PubMed ID: 33812404 [TBL] [Abstract][Full Text] [Related]
20. Galectin-9 contributes to the pathogenesis of atopic dermatitis Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q Front Immunol; 2022; 13():952338. PubMed ID: 35967337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]